Discover
About

About Molecule

We propel science from lab to life, fueled by a community committed to human progress

Molecule is a decentralized biotech protocol, building a web3 marketplace for research-related IP. Our platform and scalable framework for biotech DAOs connects academics and biotech companies with quick and easy funding, while enabling patient, researcher, and funder communities to directly govern and own research-related IP.

Our ecosystem

Dive into the Molecule source code

Molecule is the knowledge base for the protocol, the Research Marketplace, BioDAOs, and IP-NFTs. Explore the docs to understand how we connect scientists, funders, and patients, or dive into the code on GitHub to see the infrastructure powering decentralized science.
Molecule ecosystem

The team

Scientists, engineers, lawyers, and operators building the future of biotech — alongside the contributors and advisors who shape our direction.

Core team

Paul Kohlhaas
Paul Kohlhaas

Founder and Chairman

Serial entrepreneur, economist and web3 engineer on a mission to build public utility networks.

Benjamin Snipes
Benjamin Snipes

Chief Legal Officer

Benjamin Snipes (JD, MBA, LLM) is based in the U.S. He has over 20 years of experience advising clients in international taxation, securities law, and emerging technologies.

Kevin Noessler
Kevin Noessler

Chief Product Officer

Seasoned product professional passionate about leveraging emerging technologies to drive innovation in the digital asset space. Strong advocate for blockchain and it's transformative potential.

Aaron Weaver
Aaron Weaver

Chief Commercial Officer

Aaron is responsible for strategy and IP commercialisation. He is a trained financial and legal professional, who spent a significant amount of time as a life sciences venture capitalist.

Chris Byrnes
Chris Byrnes

IP Legal Advisor

Lawyer and legal hacker reimagining IP as a common good.

Jose Pinto
Jose Pinto

Swiss Legal Counsel

International tax & tech lawyer.

Benji Leibowitz
Benji Leibowitz

Project Lead at Pump.Science

Benji has work experience in academic research, investment banking, venture capital, and computational biology research and development.

Jillian Casalini
Jillian Casalini

Head of Growth at Pump.Science

Brand marketer with experience at the largest pharmaceutical company and in Web3 growth.

María Sanmartín
María Sanmartín

Lead Product Designer

Inspired by nature and people. I'm an explorer of the world, a creative mind, and an optimistic designer. Making positive impact through UX.

Nour Karoui
Nour Karoui

dApp Protocol Engineer

dApp Protocol Engineer with more than 1 year experience in Typescript / NodeJs applications. Passionate about the web3 world and excited to learn more about it.

Phill Lee
Phill Lee

Protocol Architect

With a PhD in Nanotechnology and experience leading Web3 projects for global brands, Phill applies a rigorous, analytical approach to designing scalable decentralized systems. Driven by decentralized science’s potential to reshape innovation.

Tom Ploem
Tom Ploem

Full Stack Engineer

A passionate full stack engineer with a focus on web technologies that positively impact society. I thrive in fast-moving environments, building products that make a difference.

Vladimir Demidov
Vladimir Demidov

Senior Web3 Engineer

Have a Degree in Designing Biomedical Equipment and super passionate about Blockchain, especially Solana.

Jesse Hudson
Jesse Hudson

Legal Advisor

Attorney & anthropologist with 10+ years advising startups in web2, web3, and life sciences.

Manuel Meinert
Manuel Meinert

Senior Web3 Engineer

Blockchain engineer dedicated to decentralization's transformative power to traditional systems. Combines institutional-grade Web3 experience with the mission to democratize scientific innovation.

Lukas Weidener
Lukas Weidener

DAO/Web3 Expert

Academic researcher and medical doctor with a focus on Web3, DAOs and DeSci

Ella McCarthy-Page
Ella McCarthy-Page

SciComms Lead

Background in biochemistry and materials science, but an affinity for writing. I'm of the staunch belief that communication is integral to scientific progression.

Jingwei Zhang
Jingwei Zhang

Scientific Assistant to the CEO

PhD candidate in Cancer Immunology with experience in biopharma consulting and venture capital. Passionate about advancing innovation across the biopharma ecosystem, with a focus on accelerating patient-centric solutions and driving meaningful impact

Rafael Alain Rolli
Rafael Alain Rolli

Scientific Assistant to the CEO

Rafael has a background in molecular biology and bioengineering, and works at Molecule to bridge biotech and Web3, supporting scientific due diligence, tokenized IP commercialization, and decentralized drug development.

Lale Ludmilla Mahrt
Lale Ludmilla Mahrt

Senior Finance Manager

Senior Finance Manager with a focus on crypto tax, cross-border accounting, and scalable financial operations for Web3 and DeFi projects. Lale brings structure and compliance to fast-moving ecosystems.

Elena Cîrnealā
Elena Cîrnealā

Office Manager

With a background in social work studies, Elena cultivates harmonious and efficient work environments driven by both efficiency and a human touch.

Abi Lambert
Abi Lambert

People & Talent Manager

People & Talent professional with a passion for building high-performing teams in web3 and deep tech. Committed to connecting top talent with mission-driven organisations to drive innovation and growth.

Contributors & Advisors

Mo Koyfman
Mo Koyfman

Board Member

Founder and General Partner at Shine Capital.

James Brodie
James Brodie

Board Member

Chief Investment Officer at ID Theory. Blockchain researcher.

Paxton Major
Paxton Major

Board Member

Senior Associate at Northpond Ventures.

Patrick Malone
Patrick Malone

Advisor

Principal at KdT Ventures. Physician-scientist turned investor.

Chris Leiter
Chris Leiter

Advisor

Founder & General Partner of Atria Ventures.

Sebastian Brunemeier
Sebastian Brunemeier

Advisor

Geroscientist and VC. Building and investing in geroscience companies that address the molecular mechanisms of aging.

Jack Scannell
Jack Scannell

Advisor

CEO at Etheros Pharamaceuticals. R&D innovation expert who coined the term Eroom's law.

Niklas Rindtorff
Niklas Rindtorff

Advisor

LabDAO, Physician Scientist. Building open tools to accelerate progress.

Vincent Weisser
Vincent Weisser

Advisor

Founder and CEO of Prime Intellect, Advisor to Molecule on AI, DeSci and Ecosystem

Michael Langer
Michael Langer

Advisor

Co-Founder and Managing Partner of T.Rx Capital.

Want to join Molecule?

Molecule is looking for talented people to help us democratise drug development. Visit our careers page to apply.

03 -- The pipeline

From data to ownership, in one pipeline

Once your Lab exists, it carries the project through every stage of commercializing your science.

01
Capture Your research

Upload your data into an encrypted data room and bring in collaborators by email, each with the right level of access, so the work stays confidential while the team moves it forward.

02
Tokenize your intellectual property

Tokenize your research via the Molecule Protocol, turning research that was hard to value into something your community can fund and hold.

03
Raise funding and report your progress

Open funding through tokens, while your public project page and activity feed connect the work and its data to the people backing it.

04
Turn your community into owners

When the time is right, Coin-to-Company gives locked token holders a compliant path to real equity in the company behind the science.

“We're currently utilizing the Molecule platform and its IPT model to further fund our research. This revolutionary concept of IP fractionalization allows community involvement in the drug development process, creating a mutually beneficial situation. For us, it enables unlocking additional capital in a collaborative manner. For the community, it gives them an opportunity to directly support projects in a manner previously unavailable.”

Michael Torres - CEO of ArtanBio